Redirecting AAV vectors to extrahepatic tissues
Molecular Therapy · 2023-12 · 31 (12) · 3371-3375
DOI: 10.1016/j.ymthe.2023.10.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Therapy, 2023-12. Verfasst von Aravind Asokan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Duke University School of Medicine, Durham, NC, USA; Department of Molecular Genetics & Microbiology, Duke University School o…. Hauptthemen laut MEDLINE: Dependovirus, Gene Transfer Techniques. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
Recombinant adeno-associated viral (AAV) vectors are the current benchmark for systemic delivery of gene therapies to multiple organs in vivo. Despite clinical successes, safe and effective gene delivery to extrahepatic tissues has proven challenging due to dose limiting toxicity arising from high liver uptake of AAV vectors. Deeper understanding of AAV structure, receptor biology, and pharmacology has enabled the design and engineering of liver-de-targeted capsids ushering in several new vector candidates. This next generation of AAVs offers significant promise for extrahepatic gene delivery to cardiovascular, musculoskeletal, and neurological tissues with improved safety profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Duke University School of Medicine, Durham, NC, USA; Department of Molecular Genetics & Microbiology, Duke University School of Medicine, Durham, NC, USA; Department of Biomedical Engineering, Duk…
- Vertex Pharmaceuticals, 50 Northern Avenue, Boston, MA, USA. Electronic address: shen_shen@vrtx.com.
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIAMS NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- University of North Carolina Wilmington
- National Institutes of Health
- National Heart Lung and Blood Institute
Zitieren
APA
Asokan, A., & Shen, S. (2023). Redirecting AAV vectors to extrahepatic tissues. Molecular Therapy, 31(12), 3371-3375. https://doi.org/10.1016/j.ymthe.2023.10.005
Vancouver
Asokan A, Shen S. Redirecting AAV vectors to extrahepatic tissues. Molecular Therapy. 2023;31(12):3371-3375. doi:10.1016/j.ymthe.2023.10.005
BibTeX
@article{Asokan2023,
author = {Asokan, Aravind and Shen, Shen},
title = {Redirecting AAV vectors to extrahepatic tissues},
journal = {Molecular Therapy},
year = {2023},
volume = {31},
number = {12},
pages = {3371--3375},
doi = {10.1016/j.ymthe.2023.10.005}
}
EUVIMED